Influenza A Reduction

Facility
Kitasato Research Center for Environmental Science
Download
Full Report

Background

Technology tested was the bipolar ionization technology used in the 7000 and BAR series. Objective was to evaluate the efficacy of the 7000 series and the Plasma BAR in reducing Influenza A (H1N1) virus.

Methodology

The 0.2 m3 acrylic test chamber was put into biological safety cabinet. The D5 device and fan were then placed in the test chamber. The virus suspensions were sprayed into the chamber using a compressor-type nebulizer NE-C16 (OMRON) into the test chamber for 5 minutes at an air flow ratio of approximately 0.2 mL/min.

Summary of Results

The device reduced 86.6% of Influenza A virus after one hour.

Contact

USA Headquarters
3540 Toringdon Way, Suite 200 Charlotte, NC  28277
1 866 508 1118
info@wellairsolutions.com

Ireland Headquarters
DCU Innovation Campus
Old Finglas Road
Glasnevin, Dublin D11 KXN4
+353 1 907 2750
info@wellairsolutions.com

Contact WellAir

Social

Partners